Kwality Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 562.03 million compared to INR 881.88 million a year ago. Revenue was INR 565.54 million compared to INR 890.26 million a year ago. Net income was INR 71 million compared to INR 158.74 million a year ago. Basic earnings per share from continuing operations was INR 6.82 compared to INR 15.2 a year ago. Diluted earnings per share from continuing operations was INR 6.82 compared to INR 15.2 a year ago.
For the nine months, sales was INR 1,822.26 million compared to INR 3,921.38 million a year ago. Revenue was INR 1,837.07 million compared to INR 3,940.48 million a year ago. Net income was INR 267.51 million compared to INR 1,098.47 million a year ago. Basic earnings per share from continuing operations was INR 25.38 compared to INR 105.49 a year ago. Diluted earnings per share from continuing operations was INR 25.38 compared to INR 105.49 a year ago.